Vext Science Inc (OTCPK:VEXTF)
$ 0.1865 0.00145 (0.78%) Market Cap: 45.22 Mil Enterprise Value: 80.28 Mil PE Ratio: 0 PB Ratio: 0.48 GF Score: 61/100

Q4 2023 Vext Science Inc Earnings Call Transcript

May 10, 2024 / 05:00PM GMT
Release Date Price: $0.2222 (+8.07%)

Key Points

Positve
  • Vext Science Inc (VEXTF) has enhanced its balance sheet flexibility, positioning its Arizona operations for long-term growth and profitability.
  • In Ohio, Vext Science Inc (VEXTF) generated revenue of $34.8 million for the full year 2023 and adjusted EBITDA of $5.5 million, demonstrating strong financial performance despite market challenges.
  • The company has successfully expanded its footprint in Ohio, adding two additional dispensaries and expecting to close on two more in 2024, which will enhance its market share and cash flow as the market transitions to adult use.
  • Vext Science Inc (VEXTF) has a solid balance sheet with $8.7 million in cash as of December 31, 2023, and no material unfunded growth capital expenditures planned for the year.
  • The company's Arizona dispensaries continue to outperform the state average in terms of customer traffic, transactions, and unit sales, thanks to effective store management and targeted promotional discounts.
Negative
  • Vext Science Inc (VEXTF) faced industry-specific hurdles such as overproduction and falling wholesale prices in Arizona, impacting the overall market.
  • The company recorded a 1.7% decrease in revenue from $35.4 million in 2022 to $34.8 million in 2023, mainly due to weakening revenue from Arizona operations.
  • Adjusted EBITDA for the year 2023 was down compared to $15 million in 2022, with adjusted EBITDA margins decreasing to 16%.
  • The company anticipates operating expenses as a percentage of revenue to remain elevated for the first half of 2024 due to necessary expenses to take advantage of the Ohio recreational market.
  • Vext Science Inc (VEXTF) expects continued market pressures and challenges in the Arizona market into the first quarters of 2024, with ongoing pricing pressure and a tough consumer market.
Operator

Thank you for standing by. This is the conference operator. Welcome to the Vext Science's fourth quarter and fiscal 2023 financial results conference call. (Operator Instructions) The conference is being recorded. (Operator Instructions) I would now like to turn the conference over to Jonathan Ross. Please go ahead.

Jonathan Ross
Vext Sciences - Investor Relations

Thanks, operator. Good morning, everyone, and thanks for joining us today. Bank's Fourth Quarter and Fiscal Year 2023 financial results were released earlier this morning. The press release, financial statements and MD&A are available on CEDAR plus as well as on the bank's website at Fox science.com. We would like to remind listeners that portions of today's discussion include forward-looking statements and that forward-looking statements are included in today's filings. There can be no assurance that these forward-looking statements will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results contained therein will materialize. Risks

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot